This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Valery Thammalaksa: Innovator in Pharmaceutical Research
Introduction
Valery Thammalaksa is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative treatments targeting specific kinases.
Latest Patents
Valery holds a patent for Mnk1 or Mnk2 inhibitors. The present invention relates to the use of pyrazolopyrimidine compounds for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 and/or variants thereof. This patent highlights her expertise in creating effective therapeutic solutions.
Career Highlights
Valery is currently employed at Boehringer Ingelheim International GmbH, where she continues to advance her research and development efforts. Her work focuses on innovative approaches to combat diseases through targeted kinase inhibition.
Collaborations
Valery collaborates with esteemed colleagues, including Thomas Stephen Coulter and Steven Taylor. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Valery Thammalaksa is a trailblazer in the pharmaceutical industry, with a focus on kinase inhibitors that hold promise for treating various diseases. Her contributions and collaborations underscore her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile